Pluristem Therapeutics Inc (PSTI)

stock, market, tablet, screen, trade, forex, graph, chart, touch, rate, business, global, data, interest, information, hand, index, visual, growth, finger, internet, nyse, pc, retail,

Hedge Fund and Insider Trading News: Daniel Loeb, Starboard Value LP, Sachem Head Capital Management, Pluristem Therapeutics Inc. (PSTI), Tradeweb Markets Inc (TW), and More

Cerner Stock Jumps on Starboard Director Appointments, Buyback (TheStreet) Shares of health care technology provider Cerner (CERN) jumped Tuesday after...

Keep Reading →

April 9 - Hedge Funds, Insider Trading - Comments

Hedge Fund and Insider Trading News: Larry Robbins, Point72 Asset Management, NII Holdings (NIHD), Marchex, Inc. (MCHX), Corvus Pharmaceuticals Inc (CRVS), and More

The 7 Most Undervalued Stocks In Larry Robbins’ Portfolio (Benzinga) Larry Robbins is a hedge fund manager and CEO of Glenview Capital Management...

Keep Reading →

March 22 - Hedge Funds, Insider Trading - Comments

test, cancer, researcher, research, dna, bio, clean, modern, chemistry, human, white, medical, sample, pipette, life, culture, laboratory, biotechnology, genetic, disease,

Pluristem Therapeutics Inc. (PSTI) To Begin CLI Phase III Trial Enrolling Only 250 Patients, With FDA Blessing

If we could point to one thing that keeps Big Pharma on top and smaller pharmaceutical companies dependent, it’s the exorbitant costs of phase III trials...

Keep Reading →

January 11 - News, Stock Analysis - Comments

Healthcare Careers That Require a Master’s Degree

Why Pluristem Therapeutics Inc. (PSTI) Is So Undervalued – The Market Is Ignoring Manufacturing

The entirety of the long investment game comes down to being able to accurately spot the undervalued. Undervaluation exists for many reasons. In biotech...

Keep Reading →

November 3 - News, Stock Analysis - Comments

Pluristem Therapeutics Inc. (PSTI) Gears Up For Critical Blood Stem Cell Trial

Investors who play the developing biotech niche are always on the lookout for shortcuts to approval. A shortcut can come in two ways. First, they can...

Keep Reading →

September 19 - News, Stock Analysis - Comments

10 Pharmacist Shortage Countries in Need of Pharmacists in 2017

Will Pluristem Therapeutics Inc. (PSTI) Succeed in CLI Where Sanofi SA (ADR) (SNY) Failed?

It’s every junior biotech company’s dream to be accepted into an accelerated approval pathway for a potentially blockbuster drug. Very few achieve...

Keep Reading →

August 11 - News, Stock Analysis - Comments

Highest Paid Medical Technicians in America

Here’s A Look At Two Promising CLI Companies And Their Near Term Milestones – Pluristem Therapeutics Inc. (PSTI) Cesca Therapeutics Inc (KOOL)

Stem cell therapy is one of the most exciting areas of development stage healthcare right now, and it’s being put to the test in a wide range of potential...

Keep Reading →

August 3 - News, Stock Analysis - Comments

Japan is Breathing Life into the Stem Cell Space, Astellas Pharma (ALPMF) & Pluristem Therapeutics Inc. (PSTI) Are Benefiting

Japan is the stem cell capital of the world. From the Nobel winning efforts of Shinya Yamanaka in the field of mature to pluripotent stem cell reprogramming...

Keep Reading →

July 21 - News, Stock Analysis - Comments

Why AMC Entertainment, Winnebago Industries and Three Other Stocks Are Trending Today

Markets inched higher on Wednesday as investors await the UK’s fateful decision to stay in or leave the EU. Some stocks are in the spotlight today,...

Keep Reading →

June 22 - Market Movers, News - Comments

Posts Tagged ‘Pluristem Therapeutics Inc (PSTI)’